Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06286761 · ClinicalTrials.gov registry record

Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)

A clinical trial of Obesity, sponsored by Bettina Mittendorfer.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT06286761: Recruiting study of Obesity, sponsored by Bettina Mittendorfer.

NCT06286761 is a study of Obesity that is actively recruiting participants, run by Bettina Mittendorfer. The registered enrollment target is 100 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06286761, a study of Obesity, is actively recruiting participants, sponsored by Bettina Mittendorfer.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases (obesity, pre-diabetes and type-2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, cardiovascular disease, etc.), nutrition, and metabolism (the process by which a substance is handled in your body) at the University of Missouri. As technology changes and we start to use new testing methods, it is necessary to compare results from old tests, equipment and devices and new tests, equipment, or devices and the reproducibility of these measurements to make sure we are getting accurate results. Reproducibility means performing the same test more than once to see if the same results can be achieved each time.

Primary Outcome

insulin, C-peptide, glucagon, substrates (free fatty acids, glucose, ketone bodies) and biomarkers of substrate metabolism (e.g., cytokines and adipokines)

Conditions Studied

Interventions

  • OTHER endothelial cell collection

Study Locations (1)

Missouri

  • University of Missouri School of Medicine - Columbia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-05-08
Est. Completion 2028-03
Bettina Mittendorfer

4 total trials

What NCT06286761 shows while recruiting

NCT06286761 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which endothelial cell collection is the first listed.

NCT06286761 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT06286761 about?

NCT06286761 is a clinical study titled "Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)". The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases (obesity, pre-diabetes and type-2 diabetes, dyslipi...

What is the current status of trial NCT06286761?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-05-08. Estimated completion is 2028-03.

What conditions does trial NCT06286761 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT06286761?

The interventions under investigation include: endothelial cell collection (OTHER).

Who is sponsoring clinical trial NCT06286761?

This trial is sponsored by Bettina Mittendorfer, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06286761 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06286761's enrollment target sits among peer trials

100 478th of 1053 higher than 555 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06286761, the US trial registry maintained by the National Library of Medicine. NCT06286761 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.